Sign in to view content

Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process

Raj K. Maturi, MD

Video
Published 2019

Related

A Biocompatible Basal Membrane to Restore Age-Related Macular Degeneration Photoreceptor Damage
Stanislao Rizzo, MD
Annual Meeting Talks
2019
Safety and Efficacy of CRISPR-Based Genome Editing for Neovascular AMD
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2023
Episode 119: 2018 ASRS Annual Meeting Post-Mortem Including Protocol S 5-Year Results
Jayanth Sridhar, MD
Member Podcasts
2018

Category: AMD-Neovascular

See more